source
- Abivax's new ulcerative colitis data eases safety worries, sending shares up 25%Abivax released additional data on its experimental ulcerative colitis drug obefazimod. Earlier trial results had shown strong efficacy but raised safety concerns after several cancer cases were r…
- FDA reviewers recommend against adding seven peptides to bulk drug list for compoundingFDA reviewers have advised that seven widely used peptides should not be added to the FDA's bulk drug substance list for compounding. Their recommendation comes before an upcoming advisory committe…